Search
for
Sort by
Research 331–360 of 375
- Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Improvement of female pattern hair loss with bicalutamide: a time-dependent process
- Quercetin Promotes Production of Secondary Hair Follicle Stem Cells in Cashmere Goat: A Mechanistic Study
- Postnatal determinants of testicular germ cell tumor by histological subtypes: The EPSAM1 and EPSAM2 studies
- Activity‐based therapeutic algorithm for folliculitis decalvans: A practical tool for effective management
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Patient and Clinician‐Reported Outcomes and Adherence to Calcipotriene/Betamethasone Dipropionate PAD‐Cream in Treatment of Scalp Psoriasis in Adults: An Interim Analysis of the PRO‐SCALP Study
- 20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- Application of Ultraviolet-Induced Fluorescence Trichoscopy (UVFT) in Hair and Scalp Diseases
- Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience
- Organoids in skin wound healing
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Androgenetic Alopecia: A Review
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
- Estimating the burden of skin diseases using patient‐reported daily time trade‐off as a measure of disease impact and unmet needs
- Wait times and health care utilization among refugee patients in dermatology: A retrospective chart review
- Apoptotic dysregulation mediates stem cell competition and tissue regeneration
- Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Double Network Physical Crosslinked Hydrogel for Healing Skin Wounds: New Formulation Based on Polysaccharides and Zn2+